3:28 PM
 | 
Dec 04, 2018
 |  BC Extra  |  Politics & Policy

Medicare bill aims to block drugmakers from misclassifying drugs

A bipartisan bill introduced Tuesday by members of the Senate Finance Committee would prevent drugmakers from profiting by misclassifying drugs to Medicare as generics.

The bill is in response to a lawsuit against Mylan N.V. (NASDAQ:MYL) for misclassifying its...

Read the full 176 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >